TickerFacts.

Company research / MLSS

Milestone Scientific Inc. (MLSS)

Build a valuation ↗↓ Download CSV

SEC name MILESTONE SCIENTIFIC INC. · CIK 0000855683 · NYSE · Orthopedic, Prosthetic & Surgical Appliances & Supplies

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Milestone Scientific Inc. reported revenue of $8.97M. Revenue grew 4.0% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $9.42M.

Key ratios (year ended 2025-12-31)

71.4%
Gross margin
-63.5%
Operating margin
-63.8%
Net margin
-203.4%
Return on year-end equity
4.0%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 10-Q (quarterly report) · 2026-08-13

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$9.42M$8.97M$8.63M$9.83M$8.81M$10.30M$5.44M$8.37M$9.62M$11.28Mn/a
Cost of Revenue$2.80M$2.57M$2.20M$3.03M$3.91M$3.99M$1.82M$2.66M$5.19M$4.31M$4.18M
Gross Profit$6.62M$6.41M$6.43M$6.79M$4.90M$6.31M$3.62M$5.72M$4.43M$6.97M$6.31M
R&D Expense$35.2K$449.5K$858.8K$701.4K$1.15M$878.2K$307.9K$189.9K$245.6K$272.7K$1.27M
Operating Income-$4.10M-$5.70M-$6.76M-$7.11M-$8.83M-$7.38M-$7.45M-$4.00M-$8.00M-$5.23M-$6.51M
Depreciation & Amortization$78.3K$78.2K$37.4K$61.9K$63.8K$73.8K$95.9K$100.5K$881.3K$573.1Kn/a
EBITDA-$4.03M-$5.62M-$6.72M-$7.04M-$8.76M-$7.30M-$7.36M-$3.90M-$7.12M-$4.66Mn/a
Net Income-$4.14M-$5.72M-$4.71M-$6.93M-$8.71M-$6.82M-$7.34M-$7.52M-$7.43M-$5.19M-$5.95M
EPS (Diluted)n/a-$0.07-$0.06n/an/a-$0.10-$0.12-$0.16-$0.21-$0.16-$0.22
Total Assets$8.35M$7.81M$9.80M$11.37M$13.70M$19.81M$19.57M$6.56M$6.40M$15.63M$14.18M
Total Liabilities$4.88M$4.99M$3.96M$3.36M$3.70M$3.59M$3.46M$4.93M$4.87M$8.13M$5.65M
Shareholders' Equity$3.47M$2.81M$5.83M$8.01M$10.23M$16.37M$16.20M$1.70M$1.54M$7.24M$8.50M
Cash & Equivalentsn/a$1.11M$3.26M$2.98M$8.72M$14.76M$14.22M$1.52M$743.4K$2.64M$3.60M
Operating Cash Flow-$642.6K-$2.92M-$2.92M-$5.33M-$6.03M-$4.03M-$6.98M-$1.78M-$1.63M-$1.23M-$5.40M
Capital Expenditures$15.1K$15.1K$10.1Kn/a$8.5K$15.2K$21.4K$9.9K$7.4K$6.0K$15.3K
Free Cash Flow-$657.8K-$2.93M-$2.93Mn/a-$6.04M-$4.05M-$7.01M-$1.79M-$1.64M-$1.24M-$5.41M
Shares Outstanding88.76M80.45M78.01M75.85M69.27M68.12M64.14M49.38M33.83M33.16M30.42M
Weighted Average Diluted Sharesn/a82.06M79.79Mn/an/a68.83M63.06M45.74M35.30M32.70M26.97M
EPS (Basic)n/a-$0.07-$0.06-$0.10-$0.12-$0.10-$0.12-$0.16-$0.21-$0.16-$0.22

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView